Region Skane Angelholms Sjukhus

The Region Skane Angelholms Sjukhus is advancing care for patients with diabetic foot ulcer by testing novel topical antimicrobials to shorten healing time and reduce infection complications.

• Evaluation of local antimicrobial agents
• Assessment of time‑to‑healing outcomes
• Implementation of randomized double‑blind methodology
• Integration of advanced wound‑care protocols

This research aims to identify more effective treatments that can be adopted in routine practice, improving recovery rates for individuals affected by bacterial infections of the foot.

In the Urologmottagningen, investigators are comparing adjuvant gemcitabine with mitomycin to enhance recurrence‑free survival for patients with non‑muscle invasive bladder cancer at intermediate risk.

• Adjuvant intravesical chemotherapy strategies
• Risk‑adjusted patient selection
• Focus on recurrence‑free survival metrics
• Collaboration across oncology and urology specialties

The study seeks to refine therapeutic options that could lower tumor recurrence rates and inform future clinical guidelines for bladder cancer management.